154 results on '"Tschopp Jm"'
Search Results
2. The best treatment for the first episode of primary spontaneous pneumothorax: an unanswered question - Reply
- Author
-
UCL, Tschopp, JM, Boutin, C, Astoul, P, Janssen, JP, Bolliger, CT, Delaunois, Luc, Driesen, P, Tassi, G, Perruchoud, AP, UCL, Tschopp, JM, Boutin, C, Astoul, P, Janssen, JP, Bolliger, CT, Delaunois, Luc, Driesen, P, Tassi, G, and Perruchoud, AP
- Published
- 2003
3. Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study
- Author
-
UCL - MD/MINT - Département de médecine interne, Tschopp, JM, Boutin, C, Astoul, P, Janssen, JP, Grandin, S, Bolliger, CT, Delaunois, Luc, Driesen, P, Tassi, G, Perruchoud, AP, ESMEVAT team, UCL - MD/MINT - Département de médecine interne, Tschopp, JM, Boutin, C, Astoul, P, Janssen, JP, Grandin, S, Bolliger, CT, Delaunois, Luc, Driesen, P, Tassi, G, Perruchoud, AP, and ESMEVAT team
- Abstract
Simple thoracoseopic talcage (TT) is a safe and effective treatment of primary spontaneous pneumothorax (PSP). However, its efficacy has not previously been estimated in comparison with standard conservative therapy (pleural drainage (PD)). In this prospective randomised comparison of two well-established procedures of treating PSP requiring at least a chest tube, cost-effectiveness, safety and pain control was evaluated in 108 patients with PSP (61 TT and 47 PD). Patients in both groups had comparable clinical characteristics. Drainage and hospitalisation duration were similar in TT and PD patients. There were no complications in either group. The immediate success rate was different: after prolonged drainage (>7 days), 10 out of 47 PD patients, but only I out of 61 TT patients required a TT as a second procedure. Total costs of hospitalisation including any treatment procedure were not significantly different between TT and PD patients. Pain, measured daily by visual analogue scales, was statistically higher during the first 3 days in TT patients but not in those patients receiving opiates. One month after leaving hospital, there was no significant difference in residual pain or full working ability: 20 out of 58 (34%) versus 10 out of 47 (21%) and 36 out of 61 (59%) versus 26 out of 39 (67%) in TT versus PD groups, respectively. After 5 yrs of follow-up, there had been only three out of 59 (5%) recurrences of pneumothorax after TT, but 16 out of 47 (34%) after conservative treatment by PD. Cost calculation favoured TT pleurodesis; especially with regard to recurrences. In conclusion, thoracoscopic talc pleurodesis under local anaesthesia is superior to conservative treatment by chest tube drainage in cases of primary spontaneous pneumothorax that fail simple aspiration, provided there is efficient control of pain by opioids.
- Published
- 2002
4. Pneumologie: Highligths 2006 en pneumologie
- Author
-
Tschopp, JM, primary
- Published
- 2007
- Full Text
- View/download PDF
5. Pneumologie: Pneumologische Schlaglichter 2006
- Author
-
Tschopp, JM, primary
- Published
- 2007
- Full Text
- View/download PDF
6. Lungenödem
- Author
-
Tschopp, JM, primary and Pernet, R, additional
- Published
- 2002
- Full Text
- View/download PDF
7. Oedème pulmonaire
- Author
-
Tschopp, JM, primary and Pernet, R, additional
- Published
- 2002
- Full Text
- View/download PDF
8. Occupational exposure to inhalative irritants and methacholine responsiveness
- Author
-
Leuenberger, Philippe, primary, Schindler, Christian, additional, Schwartz, Joel, additional, Ackermann-Liebrich, Ursula, additional, Tara, D, additional, Perruchoud, AP, additional, Wüthrich, B, additional, Zellweger, JP, additional, Blaser, K, additional, Bolognini, G, additional, Bongard, JP, additional, Brändli, O, additional, Domenighetti, G, additional, Elsasser, S, additional, Grizé, L, additional, Karrer, W, additional, Keller, R, additional, Künzli, Nino, additional, Medici, T, additional, Schöni, MH, additional, Solari, G, additional, Tschopp, JM, additional, Villiger, B, additional, and Zemp, E, additional
- Published
- 2000
- Full Text
- View/download PDF
9. Transoesophageal Doppler monitoring for fluid and hemodynamic treatment during lung surgery.
- Author
-
Diaper J, Ellenberger C, Villiger Y, Robert J, Tschopp JM, Licker M, Diaper, John, Ellenberger, Christoph, Villiger, Yann, Robert, John, Tschopp, Jean-Marie, and Licker, Marc
- Abstract
Introduction: Patients undergoing lung resection are vulnerable to fluid overhydration. Recently, goal-directed fluid therapy using transoesophageal Doppler monitoring (TDM) has been shown to improve postoperative clinical outcome. The aim of this study was to assess the feasibility of TDM during open-chest procedures for guiding fluid and hemodynamic treatment.Methods: We performed an observational prospective study including 127 high-risk patients undergoing lung cancer resection. A restrictive fluid strategy was targeted to achieve a stroke volume index (SVI) > or = 30 ml/min/m(2). Besides standard hemodynamic measurements, stroke volume index (SVI), corrected flow time (FTc), maximal acceleration (MA) and velocity (PV) were recorded during two-lung ventilation (TLV) and one-lung ventilation (OLV).Results: Doppler flow tracings could not be obtained in 4 patients during TLV (3.1%) and in 6 patients during OLV (4.9%). Preoperatively, 96 pts had SVI > or = 30 ml/min/m(2) (N-SVI group) whereas 21 patients had SVI < 30 ml/min/m(2) (L-SVI group) associated with lower FTc values. After OLV, SVI transiently decreased (-17 +/- 9%; P < 0.05) in the N-SVI group whereas in the L-SVI group, SVI increased steadily until the end of surgery (+40 +/- 12%). Other flow-related parameters as well as heart rate and mean arterial pressure remained unchanged. Surgical and medical characteristics did not differ between the two groups, except that larger volumes of colloids were administered intraoperatively in the L-SVI group (+2.2 +/- 0.6 ml/min/h compared with N-SVI group, P < 0.05).Conclusion: In thoracic surgical patients, TDM can be used to detect and correct low flow conditions and to guide hemodynamic support during the intraoperative period. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
10. Influence of renal failure on the hepatic clearance of bufuralol in man
- Author
-
L. Balant, A. Marmy, J. Fabre, Thomas N. Tozer, R. John Francis, and Tschopp Jm
- Subjects
Adult ,Male ,medicine.medical_specialty ,Metabolic Clearance Rate ,Metabolite ,Adrenergic beta-Antagonists ,Pharmacology ,Kidney ,First pass effect ,chemistry.chemical_compound ,Pharmacokinetics ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,General Pharmacology, Toxicology and Pharmaceutics ,Aged ,Volume of distribution ,Bufuralol ,Kidney metabolism ,Biological activity ,Metabolism ,Middle Aged ,Kinetics ,Endocrinology ,Liver ,chemistry ,Ethanolamines ,Female ,Kidney Diseases ,Mathematics - Abstract
The beta-blocking agent bufuralol is subject to first-pass metabolism and is eliminated from the body almost entirely by biotransformation. Its major metabolite in plasma (1'-hydroxy-bufuralol) is biologically active and may contribute to the pharmacological effect of the drug. The effect of renal failure on the behavior of the parent compound and three of its metabolites was studied by comparing their kinetics in normal volunteers and in patients with severe renal insufficiency. Bufuralol was given orally to all subjects (20 mg); some of the healthy volunteers also received the drug intravenously (5 mg). Renal failure was found to be associated with a marked increase of the areas under the plasma concentration-time curves of the parent compound, whereas its halflife of elimination was not markedly influenced. The behavior of 1'-hydroxy-bufuralol was consistent with a decreased renal clearance. The behavior of bufuralol in patients with renal failure was analyzed using the clearance approach. From this analysis it appears that the presystemic biotransformation of bufuralol is decreased in renal failure and that changes in systemic clearance are compensated in our patients by modifications of the volume of distribution, resulting in little net change in the halflife of elimination.
- Published
- 1980
11. Pleurodesis by talc poudrage under simple medical thoracoscopy: an international opinion.
- Author
-
Tschopp JM, Schnyder JM, Astoul P, Noppen M, Froudarakis M, Bolliger CT, Gasparini S, Tassi GF, Rodriguez-Panadero F, Loddenkemper R, Aelony Y, and Janssen JP
- Published
- 2009
12. Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect
- Author
-
Imboden Medea, Schwartz Joel, Schindler Christian, Curjuric Ivan, Berger Wolfgang, Liu Sally L J, Russi Erich W, Ackermann-Liebrich Ursula, Rochat Thierry, Probst-Hensch Nicole M, SAPALDIA Team, SAPALDIA, Team, Ackermann-Liebrich, U., Gaspoz, JM., Leuenberger, P., Liu, LJ., Probst-Hensch, NM., Schindler, C., Rochat, T., Barthélémy, JC., Berger, W., Bettschart, R., Bircher, A., Bolognini, G., Brändli, O., Brutsche, M., Burdet, L., Frey, M., Gerbase, MW., Gold, D., Karrer, W., Keller, R., Knöpfli, B., Künzli, N., Neu, U., Nicod, L., Pons, M., Russi, E., Schmid-Grendelmeyer, P., Schwartz, J., Straehl, P., Tschopp, JM., von Eckardstein, A., Zellweger, JP., Zemp Stutz, E., Bridevaux, PO., Curjuric, I., Dratva, J., Felber Dietrich, D., Keidel, D., Imboden, M., Phuleria, H., Schaffner, E., Thun, GA., University of Zurich, and Probst-Hensch, N M
- Subjects
Male ,Health, Toxicology and Mutagenesis ,air pollution ,Air Pollutants/*toxicity ,Cohort Studies ,11124 Institute of Medical Molecular Genetics ,0302 clinical medicine ,Genes, p53 ,540 Chemistry ,Cyclin D1 ,Respiratory function ,Respiratory system ,genes ,Lung ,10038 Institute of Clinical Chemistry ,ddc:616 ,Air Pollutants ,0303 health sciences ,education.field_of_study ,respiratory function tests ,Cell cycle ,Genetic Variation ,Respiratory Function Tests ,3. Good health ,medicine.anatomical_structure ,cell cycle ,Female ,Adult ,medicine.medical_specialty ,Air Pollutants/toxicity ,Base Sequence ,Cyclin D1/genetics ,DNA Primers ,Humans ,Lung/drug effects ,Lung/physiology ,Particle Size ,Proto-Oncogene Proteins p21(ras)/genetics ,Population ,610 Medicine & health ,Context (language use) ,Biology ,Proto-Oncogene Proteins p21(ras) ,03 medical and health sciences ,FEV1/FVC ratio ,Internal medicine ,2307 Health, Toxicology and Mutagenesis ,cohort study ,medicine ,education ,030304 developmental biology ,Research ,Public Health, Environmental and Occupational Health ,10060 Epidemiology, Biostatistics and Prevention Institute (EBPI) ,2739 Public Health, Environmental and Occupational Health ,Proto-Oncogene Proteins p21(ras)/*genetics ,Cyclin D1/*genetics ,Endocrinology ,Lung/*drug effects/physiology ,030228 respiratory system ,13. Climate action ,Immunology ,570 Life sciences ,biology - Abstract
A large body of evidence underscores the adverse effect of long-term exposure to ambient particulate matter (PM) air pollution on respiratory health (Brunekreef and Forsberg 2005; Gotschi et al. 2008). Among adults in Switzerland, we have previously demonstrated cross-sectionally that residents of more polluted areas have lower lung function (Ackermann-Liebrich et al. 1997). More recently, we presented evidence from the same population-based cohort [Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA)] that decreasing exposure to airborne PM attenuated the average age-related decline in lung function. The associations were strongest for respiratory function tests reflecting small-airway function, namely, FEF25–75 [forced expiratory flow between 25% and 75% of forced vital capacity (FVC)] (Downs et al. 2007). Similar results from studies following interventions such as building bypasses for congested traffic routes (Burr et al. 2004; Hedley et al. 2002) or banning environmental tobacco smoke (ETS) exposure (Goodman et al. 2007; Menzies et al. 2006) showed that the improvements in air quality were accompanied by a decrease in cardiopulmonary mortality and an improvement in respiratory symptoms and lung function. However, it is still unknown whether all subjects benefit equally from a reduction in air pollution. Variation in genes mediating the pathobiological effect of air pollution in the lung may codetermine the degree to which a person benefits from better air quality. Experimental evidence indicates that PM alters expression of tumor protein gene p53, cyclin-dependent kinase inhibitor 1A gene (p21), and the cyclin D1 gene (CCND1) and subsequently affects cell proliferation and apoptosis of lung fibroblasts, lymphocytes, and alveolar epithelial cells (Bayram et al. 2006; Dagher et al. 2006; Nyunoya et al. 2006; Rosas Perez et al. 2007; Soberanes et al. 2006). PM is furthermore well known to induce oxidative stress in the airways (Li et al. 2008). In fact, the expression of all three gene candidates, p53, p21, and CCND1, in bronchial epithelial cells and lung fibroblasts seems to be regulated in part by redox-dependent mechanisms (Jiao et al. 2008; Ranjan et al. 2006; Yao et al. 2008). The tumor suppressor p53, a nuclear transcription factor, binds to response elements in the promoter region of many genes and plays a pivotal role in apoptosis. It induces up-regulation of the expression of many pro-apoptotic genes and down-regulation of anti-apoptotic genes (Oren et al. 2002). CCND1 (cyclin D1) is known to promote cell proliferation through cell cycle G1–S phase transition. The protein p21 (also known as Waf1 or Cip1) is a direct functional counterpart of CCND1 and an important downstream effector of p53 action that negatively regulates cell proliferation. CCND1, p21, and p53 all harbor polymorphisms of hypothesized functional relevance that have been extensively studied in the context of cancer (Choi et al. 2008; Lu et al. 2008; Zhou et al. 2007). In this study, we examined whether these polymorphisms modified the degree to which the age-related FEF25–75 decline was attenuated by reduced exposure to PM with aerodynamic diameter ≤ 10 μm (PM10).
- Published
- 2009
- Full Text
- View/download PDF
13. Impact of biomass fuel smoke on respiratory health of children under 15 years old in Madagascar.
- Author
-
Jestin-Guyon N, Ouaalaya EH, Harison MT, Ravahatra K, Rakotomizao J, Raharimanana RN, Rakotoson JL, Rajaoarifetra J, Rakotoarisoa JA, Rasamimanana G, Randriamananjara C, Ravalison B, Andrianarisoa A, Ralison A, Andriambololona R, Charpin D, Rakotomanga JDM, Rakotondrabe ID, Rasoafaranirina MO, Rakotondravola ZM, Rakotoson A, Rakotondriaka JR, Nandimbiniaina A, Ratsirahonana O, Feno P, Razafindramboa M, Rahoelina B, Tschopp JM, Coutaz M, Garrone S, L'Her P, and Raherison-Semjen C
- Subjects
- Humans, Child, Adolescent, Biomass, Cross-Sectional Studies, Birth Weight, Madagascar epidemiology, Smoke adverse effects, Air Pollution, Indoor adverse effects
- Abstract
Background: Children exposed to biomass used in households are at risk to develop diseases or respiratory symptoms. In Madagascar more than 95% of households use it daily. The main objective is to study the impact of chronic exposure to biomass on respiratory health of children under 15 years old in Madagascar., Methods: Descriptive cross-sectional study conducted with questionnaires among urban and rural population of Antananarivo and Mahajanga provinces between 2016 and 2017. Variables were collected: number of hours spent in kitchen per day, respiratory symptoms and spirometric data. Categorized symptoms score and exposure index expressing chronic exposure to biomass were analyzed with multinomial logistic regression models., Results: Of the 661 children included in the analysis, 27.7% had 1 respiratory symptom and 29.3% had 2 or more respiratory symptoms. Moderate exposure index (aOR=1.57; CI95%=[1.30-1.89]; p<0.001) and high exposure index (aOR=1.76; CI95%=[1.39-2.24]; p<0.001) were significantly associated with 1 respiratory symptom, adjusted with provinces, household members and visitors smoking, perceived discomfort related to air pollution and birthweight. Exposure index was not significantly associated with an increased risk of having 2 or more respiratory symptoms (p = 0.754)., Conclusion: Respiratory symptoms were associated with exposure to biomass, living in coastal areas, birthweight, tobacco and perceived discomfort related to air pollution. Recommendations and actions must be implemented in order to improve respiratory health related to biomass among children., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
14. New insights and improved strategies for the management of primary spontaneous pneumothorax.
- Author
-
Plojoux J, Froudarakis M, Janssens JP, Soccal PM, and Tschopp JM
- Subjects
- Blister complications, Bronchiolitis complications, Chest Tubes adverse effects, Disease Management, Humans, Male, Needles adverse effects, Paracentesis methods, Pleura anatomy & histology, Pleurodesis methods, Pneumothorax epidemiology, Practice Guidelines as Topic, Pulmonary Emphysema complications, Recurrence, Risk Factors, Talc administration & dosage, Talc therapeutic use, Thoracic Surgery, Video-Assisted methods, Thoracotomy methods, Pneumothorax physiopathology, Pneumothorax therapy, Smoking adverse effects
- Abstract
The pathophysiology and management of primary spontaneous pneumothorax (PSP) are a subject of debate. Despite advances in the understanding of its etiopathogenesis and improvements in its management, implementation in clinical practice is suboptimal. In this manuscript, we review the recent literature with a focus on PSP pathophysiology and management. Blebs and emphysema-like changes (ELC) are thought to contribute to the pathophysiology of PSP but cannot explain all cases. Recent studies emphasize the role of a diffuse porosity of the visceral pleura. Others found a relationship between smoking, occurrence of a PSP and bronchiolitis, which could be the initial pathological process leading to ELC development. Recent or ongoing studies challenge the need to systematically remove air from the pleural cavity of stable patients, introducing conservative management as a valuable therapeutic option. Evidence is growing in favour of needle aspiration instead of chest tube insertion, when air evacuation is needed. In addition, ambulatory management is considered as a successful approach in meta-analyses and is under exploration in a large randomized study. Because of a high recurrence rate of PSP, the benefit of performing a pleurodesis at first occurrence is under evaluation with interesting but not generalizable results. Better identification of 'at risk patients' is needed to improve the investigation strategy. Finally, recent publications confirm the efficacy, security and cost-effectiveness of graded talc poudrage pleurodesis to prevent PSP recurrence. In conclusion, PSP pathophysiology and management are still under investigation. The results of recently published and ongoing studies should be more widely implemented in clinical practice., (© 2019 John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
15. Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programme.
- Author
-
Carron T, Bridevaux PO, Lörvall K, Parmentier R, Moix JB, Beytrison V, Pernet R, Rey C, Roberfroid PY, Chhajed PN, Dieterle T, Joos Zellweger L, Kohler M, Maier S, Miedinger D, Thurnheer R, Urwyler P, Tschopp JM, Zuercher E, Leuppi JD, Burnand B, and Peytremann-Bridevaux I
- Subjects
- Aged, Evidence-Based Practice, Feasibility Studies, Female, Humans, Male, Patient Education as Topic, Pilot Projects, Program Evaluation, Quality of Life, Switzerland, Community-Based Participatory Research, Delivery of Health Care, Integrated, Disease Management, Pulmonary Disease, Chronic Obstructive therapy
- Abstract
Question Under Study: The aim of this study was to assess the feasibility, acceptability and effectiveness of a pilot COPD integrated care programme implemented in Valais, Switzerland., Methods: The programme was adapted from the self-management programme Living Well with COPD, and included the following elements: self-management patient-education group sessions, telephone and medical follow-ups, multidisciplinary teams, training of healthcare professionals, and evidence-based COPD care. A process and outcome evaluation of the pilot phase of the programme was conducted by means of qualitative and quantitative methods. Reach (coverage, participation rates), dosage (interventions carried out), fidelity (delivered as intended) and stakeholders' acceptance of the programme were evaluated through data monitoring and conduct of focus groups with patients and healthcare professionals. Effectiveness was assessed with pre-post analyses (before and after the intervention). The primary outcome measures were; (1) generic and disease-specific quality of life (36-Item Short Form Health Survey, Chronic Respiratory Questionnaire); and (2) hospitalisations (all-cause and for acute exacerbations) in the past 12 months. Secondary outcomes included self-efficacy, number of exacerbations and exercise capacity. Finally, controlled pre-post comparisons were also made with patients from the Swiss COPD Cohort for three common outcome measures (dyspnoea [mMRC score], number of exacerbations and smoking status)., Results: During the first 2 years of the programme, eight series of group-based education sessions were delivered to 57 patients with COPD in three different locations of the canton of Valais. Coverage objectives were achieved and attendance rate at the education sessions was high (83.6%). Patients' and healthcare professionals' reported a high degree of satisfaction, except for multidisciplinarity and transfer of information. Exploration of the effectiveness of this pilot programme suggested positive pre-post results at 12 months, with improvements in terms of health-related quality of life, self-efficacy, exercise capacity, immunisation coverage and Patient Assessment of Chronic Illness Care score. No other outcome, including the number of hospital admissions, differed significantly after 12 months. We observed no differences from the control group., Conclusions: The evaluation demonstrated the feasibility and acceptability of the programme and confirmed the relevance of mixed method process evaluation to adjust and improve programme implementation. The introduction of multidisciplinary teams in a context characterised by fragmentation of care was identified as the main challenge in the programme implementation and could not be achieved as expected. Despite this area for improvement, patients' feedback and early effectiveness results confirmed the benefits of COPD integrated care programmes emphasising self-management education.
- Published
- 2017
- Full Text
- View/download PDF
16. Factors associated with cessation of smoking among Swiss adults between 1991 and 2011: results from the SAPALDIA cohort.
- Author
-
Ayala-Bernal D, Probst-Hensch N, Rochat T, Bettschart R, Brändli O, Bridevaux PO, Burdet L, Frey M, Gerbase M, Pons M, Rothe T, Stolz D, Tschopp JM, Turk A, Künzli N, and Schindler C
- Subjects
- Adult, Age Factors, Cohort Studies, Female, Humans, Longitudinal Studies, Male, Middle Aged, Sex Factors, Switzerland, Tobacco Use Disorder psychology, Educational Status, Health Behavior, Lung physiology, Smoking Cessation statistics & numerical data
- Abstract
Introduction: Smoking is still the most preventable cause of disease and premature death in Switzerland, as elsewhere. We aimed to assess the main determinants of smoking cessation in the population-based cohort of SAPALDIA (Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults)., Methods: The SAPALDIA study was initiated in 1991 with 9651 participants aged 18 to 60 years from eight areas (S1). Follow-up assessments were conducted in 2002 (S2; 8047 participants) and 2010/11 (S3; 6088 participants). At each survey, detailed information on health and potential health-related factors was collected and lung function measured. Using logistic regression, we assessed predictors of smoking cessation between S1 and S2 and between S2 and S3., Results: In both periods, highest educational level (summary odds ratio [OR] 1.49, 95% confidence interval [CI] 1.08-2.06; ref. lowest level), FEV1/FVC <0.5 (OR 6.19, 95% CI 2.44-15.7, ref. FEV1/FVC ≥0.7), higher age in men (OR 1.02, 95% CI 1.01-1.03, per year) and overweight (OR 1.38, 95% CI 1.16-1.64) were significant predictors of smoking cessation. Nicotine dependence (OR 0.97, 95% CI 0.96-0.98, per cigarette smoked a day) and female sex between age 45 and 60 (e.g., OR 0.74, 95% CI 0.61-0.91, at age 50) were negatively associated with smoking cessation. Moreover, smokers at S2 reporting a diagnosis of depression were less likely to quit smoking by S3 (OR 0.53, 95% CI 0.30-0.93)., Conclusions: Prospective tobacco control policies in Switzerland should be addressed to women, younger persons and persons of lower education.
- Published
- 2017
- Full Text
- View/download PDF
17. Spontaneous pneumothorax: stop chest tube as first-line therapy.
- Author
-
Tschopp JM and Marquette CH
- Subjects
- Drainage, Humans, Recurrence, Chest Tubes, Pneumothorax
- Published
- 2017
- Full Text
- View/download PDF
18. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax.
- Author
-
Tschopp JM, Bintcliffe O, Astoul P, Canalis E, Driesen P, Janssen J, Krasnik M, Maskell N, Van Schil P, Tonia T, Waller DA, Marquette CH, and Cardillo G
- Subjects
- Advisory Committees, Antiperspirants, Humans, Pleurodesis, Practice Guidelines as Topic, Recurrence, Smoking adverse effects, Societies, Medical, Talc therapeutic use, Thoracic Surgery, Video-Assisted, Thoracotomy, Pneumothorax diagnosis, Pneumothorax epidemiology, Pneumothorax surgery
- Abstract
Primary spontaneous pneumothorax (PSP) affects young healthy people with a significant recurrence rate. Recent advances in treatment have been variably implemented in clinical practice. This statement reviews the latest developments and concepts to improve clinical management and stimulate further research.The European Respiratory Society's Scientific Committee established a multidisciplinary team of pulmonologists and surgeons to produce a comprehensive review of available scientific evidence.Smoking remains the main risk factor of PSP. Routine smoking cessation is advised. More prospective data are required to better define the PSP population and incidence of recurrence. In first episodes of PSP, treatment approach is driven by symptoms rather than PSP size. The role of bullae rupture as the cause of air leakage remains unclear, implying that any treatment of PSP recurrence includes pleurodesis. Talc poudrage pleurodesis by thoracoscopy is safe, provided calibrated talc is available. Video-assisted thoracic surgery is preferred to thoracotomy as a surgical approach.In first episodes of PSP, aspiration is required only in symptomatic patients. After a persistent or recurrent PSP, definitive treatment including pleurodesis is undertaken. Future randomised controlled trials comparing different strategies are required., (Copyright ©ERS 2015.)
- Published
- 2015
- Full Text
- View/download PDF
19. Spontaneous pneumothorax: time to rethink management?
- Author
-
Bintcliffe OJ, Hallifax RJ, Edey A, Feller-Kopman D, Lee YC, Marquette CH, Tschopp JM, West D, Rahman NM, and Maskell NA
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Ambulatory Care methods, Elective Surgical Procedures, Humans, Middle Aged, Pneumothorax classification, Pneumothorax etiology, Practice Guidelines as Topic, Recurrence, Risk Assessment, Secondary Prevention, Tomography, X-Ray Computed, Young Adult, Pneumothorax therapy
- Abstract
There are substantial differences in international guidelines for the management of pneumothorax and much geographical variation in clinical practice. These discrepancies have, in part, been driven by a paucity of high-quality evidence. Advances in diagnostic techniques have increasingly allowed the identification of lung abnormalities in patients previously labelled as having primary spontaneous pneumothorax, a group in whom recommended management differs from those with clinically apparent lung disease. Pathophysiological mechanisms underlying pneumothorax are now better understood and this may have implications for clinical management. Risk stratification of patients at baseline could help to identify subgroups at higher risk of recurrent pneumothorax who would benefit from early intervention to prevent recurrence. Further research into the roles of conservative management, Heimlich valves, digital air-leak monitoring, and pleurodesis at first presentation might lead to an increase in their use in the future., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
20. Spirometer Replacement and Serial Lung Function Measurements in Population Studies: Results From the SAPALDIA Study.
- Author
-
Bridevaux PO, Dupuis-Lozeron E, Schindler C, Keidel D, Gerbase MW, Probst-Hensch NM, Bettschart R, Burdet L, Pons M, Rothe T, Turk A, Stolz D, Tschopp JM, Kuenzli N, and Rochat T
- Subjects
- Adult, Aged, Bias, Cohort Studies, Female, Forced Expiratory Volume, Humans, Lung Volume Measurements instrumentation, Male, Smoking physiopathology, Ultrasonics, Young Adult, Spirometry instrumentation, Vital Capacity
- Abstract
The Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults (SAPALDIA), a population cohort study, used heated-wire spirometers in 1991 and 2002 and then ultrasonic spirometers in 2010 revealing measurement bias in healthy never smokers. To provide a practical method to control for measurement bias given the replacement of spirometer in long-term population studies, we built spirometer-specific reference equations from healthy never smokers participating in 1991, 2002, and 2010 to derive individualized corrections terms. We compared yearly lung function decline without corrections terms with fixed terms that were obtained from a quasi-experimental study and individualized terms. Compared with baseline reference equations, spirometer-specific reference equations predicted lower lung function. The mean measurement bias increased with age and height. The decline in forced expiratory volume in 1 second during the reference period of 1991-2002 was 31.5 (standard deviation (SD), 28.7) mL/year while, after spirometer replacement, uncorrected, corrected by fixed term, and individualized term, the declines were 47.0 (SD, 30.1), 40.4 (SD, 30.1), and 30.4 (SD, 29.9) mL/year, respectively. In healthy never smokers, ultrasonic spirometers record lower lung function values than heated-wire spirometers. This measurement bias is sizeable enough to be relevant for researchers and clinicians. Future reference equations should account for not only anthropometric variables but also spirometer type. We provide a novel method to address spirometer replacement in cohort studies., (© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
21. Propofol: is it really worse than midazolam in medical thoracoscopy?
- Author
-
Licker M, Diaper J, and Tschopp JM
- Subjects
- Female, Humans, Male, Anesthetics, Intravenous adverse effects, Deep Sedation methods, Midazolam adverse effects, Propofol adverse effects, Thoracoscopy
- Published
- 2015
- Full Text
- View/download PDF
22. Serum bilirubin is associated with lung function in a Swiss general population sample.
- Author
-
Curjuric I, Imboden M, Adam M, Bettschart RW, Gerbase MW, Künzli N, Rochat T, Rohrer L, Rothe TB, Schwartz J, Stolz D, Tschopp JM, von Eckardstein A, Kronenberg F, and Probst-Hensch NM
- Subjects
- Adolescent, Adult, Biomarkers blood, Body Mass Index, Cohort Studies, Female, Forced Expiratory Volume, Genotype, Humans, Linear Models, Lung physiology, Lung physiopathology, Male, Middle Aged, Respiration Disorders blood, Respiratory Function Tests, Smoking adverse effects, Spirometry, Switzerland, Vital Capacity, Young Adult, Bilirubin blood, Respiration Disorders genetics, Respiration Disorders physiopathology
- Abstract
Bilirubin is a strong antioxidant. Increased serum levels have been associated with lower respiratory disease and mortality risk. We studied the association of bilirubin with lung function in the Swiss study on Air Pollution and Lung Disease in adults (SAPALDIA) cohort. Associations between natural logarithmised bilirubin and forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC and mean forced expiratory flow between 25%-75% of FVC (FEF25-75%) were tested using multiple linear regression in the whole study population (n=4195) and strata of ever-smoking and high body mass index (BMI, defined by the highest distribution quartile). Associations were retested with single nucleotide polymorphism rs6742078, a genetic determinant of bilirubin. High bilirubin levels were significantly associated with higher FEV1/FVC and FEF25-75% overall. Upon stratification, significant associations persisted in ever-smokers, amounting to 1.1% (95% CI 0.1-2.2%) increase in FEV1/FVC, and 116.2 mL·s(-1) (95% CI -15.9-248.4 mL·s(-1)) in FEF25-75% per interquartile range of bilirubin exposure in smokers with high BMI. Associations were positive but nonsignificant in never-smokers with high BMI. Similarly, rs6742078 genotype TT was associated with increased FEV1/FVC and FEF25-75%. Our results suggest a possible protective role of bilirubin on lung tissue, which could be important for prevention and therapy.
- Published
- 2014
- Full Text
- View/download PDF
23. Sleep fragmentation and sleep-disordered breathing in individuals living close to main roads: results from a population-based study.
- Author
-
Gerbase MW, Dratva J, Germond M, Tschopp JM, Pépin JL, Carballo D, Künzli N, Probst-Hensch NM, Adam M, Zemp Stutz E, Roche F, and Rochat T
- Subjects
- Electrocardiography, Female, Humans, Male, Middle Aged, Monitoring, Physiologic, Sex Factors, Surveys and Questionnaires, Motor Vehicles, Noise adverse effects, Sleep Apnea Syndromes etiology, Sleep Deprivation etiology
- Abstract
Background: Nighttime traffic noise is associated with sleep disturbances, but sleep fragmentation and sleep-disordered breathing (SDB) have not been demonstrated in individuals living near busy roads., Methods: We asked 1383 participants to answer a health questionnaire and to undergo 24-h electrocardiogram (ECG). Nocturnal ECG records were used to calculate the very low frequency index (VLFI) interval, a surrogate marker of sleep fragmentation. Distances of participants' addresses to roadways were calculated using the VECTOR25© Swisstopo roads classification, a traffic noise proxy. Distances of homes within 100 or 50 m of major roads defined proximity to busy roads. Adjusted multivariate logistic regressions analyzed associations between the distance of home to main roads and VLFI or self-reported SDB., Results: Distance of participants' homes to main roads was significantly associated with the VLFI in women (odds ratio [OR], 1.58 [confidence interval {CI}, 1.03-2.42]; P = .038) but not in men (OR, 1.35 [CI, 0.77-2.35]; P = .295). Women under hormonal replacement therapy (HRT) were at higher risk for increased VLFI when living close to main roads (OR, 2.10 [CI, 1.20-3.68]; P = .01) than untreated women (P = .584). Associations with self-reported SDB were not statistically relevant., Conclusions: In our large population, women living close to main roads were at significantly higher risk for sleep fragmentation than men. The 2-fold higher risk for menopausal women under HRT underscores the vulnerability of this group., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
24. Primary malignant achromic melanoma of the lung.
- Author
-
Lazarou I, Purek L, Duc C, Licker MJ, Spiliopoulos A, and Tschopp JM
- Abstract
Currently, less than thirty cases of primary malignant melanoma of the lung have been reported in the literature. Thus, strict criteria for diagnosis have been published and include: malignant melanoma associated with bronchial epithelial changes; a solitary lung tumor; no prior history of skin, mucous membrane, intestinal or ocular melanoma; and absence of any other detectable tumor at the time of diagnosis. In this article we present a case of melanoma of the lung without evidence of extra-pulmonary disease.
- Published
- 2014
- Full Text
- View/download PDF
25. [Alveolar proteinosis: a cause of immunodeficiency].
- Author
-
Ben Hammoud L, Dessimoz C, Rudaz D, Ravussin P, Oggier S, and Tschopp JM
- Subjects
- Humans, Immunocompromised Host, Male, Middle Aged, Opportunistic Infections etiology, Pulmonary Alveolar Proteinosis complications, Pulmonary Alveolar Proteinosis immunology, Severity of Illness Index, Bronchoalveolar Lavage methods, Macrophages pathology, Pulmonary Alveolar Proteinosis therapy
- Abstract
Alveolar proteinosis is a rare disease, characterized by accumulation of surfactant in alveoli. Various forms have been identified (congenital, secondary or auto-immune). Treatment is to be reserved for patients that experience moderate to severe symptoms. It requires whole lung lavages, in order to clear the alveoli from the proteinaceous material. Macrophages dysfunction plays a crucial role in the development of the disease and causes immunodeficiency, which in turn can promote opportunistic infections, in patients a priori thought to be immunocompetent.
- Published
- 2013
26. [Working together for better care].
- Author
-
Tschopp JM, Hug MC, and Anchisi S
- Subjects
- Aging, Chronic Disease, Delivery of Health Care standards, Humans, Quality of Life, Delivery of Health Care organization & administration, Evidence-Based Medicine organization & administration
- Published
- 2013
27. [General internal medicine: towards a cross-disciplinary continuing education].
- Author
-
Tschopp JM, Hug MC, Petignat PA, and Della Bianca P
- Subjects
- Humans, Education, Medical, Continuing methods, Internal Medicine education
- Published
- 2012
28. Primary spontaneous pneumothorax: a diffuse disease of the pleura.
- Author
-
Grundy S, Bentley A, and Tschopp JM
- Subjects
- Humans, Pneumothorax pathology, Pneumothorax therapy, Secondary Prevention, Pneumothorax etiology
- Abstract
Primary spontaneous pneumothorax (PSP) is by definition not associated with any underlying lung disease. However, this does not mean that there is no underlying pathological process. It has become increasingly apparent over recent years that PSP is associated with diffuse and often bilateral abnormalities within the pleura and is not simply a disease caused by ruptured blebs/bullae. The pathological process includes emphysema-like changes, pleural porosity and inflammation. In this review, we summarise the recent advances in our understanding of the pathogenesis of PSP and discuss how this relates to management strategies for patients with PSP., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF
29. Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.
- Author
-
Bridevaux PO, Tschopp JM, Cardillo G, Marquette CH, Noppen M, Astoul P, Driesen P, Bolliger CT, Froudarakis ME, and Janssen JP
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Drainage methods, Female, Fever chemically induced, Humans, Male, Middle Aged, Oxygen Inhalation Therapy methods, Particle Size, Pleurodesis adverse effects, Pneumothorax surgery, Prospective Studies, Respiratory Distress Syndrome chemically induced, Secondary Prevention, Talc adverse effects, Talc chemistry, Thoracoscopy adverse effects, Young Adult, Pleurodesis methods, Pneumothorax therapy, Respiratory Distress Syndrome prevention & control, Talc administration & dosage, Thoracoscopy methods
- Abstract
The safety of talc pleurodesis is under dispute following reports of talc-induced acute respiratory distress syndrome (ARDS) and death. We investigated the safety of large-particle talc for thoracoscopic pleurodesis to prevent recurrence of primary spontaneous pneumothorax (PSP). 418 patients with recurrent PSP were enrolled between 2002 and 2008 in nine centres in Europe and South Africa. The main exclusion criteria were infection, heart disease and coagulation disorders. Serious adverse events (ARDS, death or other) were recorded up to 30 days after the procedure. Oxygen saturation, supplemental oxygen use and temperature were recorded daily at baseline and after thoracoscopic pleurodesis (2 g graded talc). During the 30-day observation period following talc poudrage, no ARDS (95% CI 0.0-0.9%), intensive care unit admission or death were recorded. Seven patients presented with minor complications (1.7%, 95% CI 0.7-3.4%). After pleurodesis, mean body temperature increased by 0.41°C (95% CI 0.33-0.48°C; p<0.001) at day 1 and returned to baseline value at day 5. Pleural drains were removed after day 4 in 80% of patients. Serious adverse events, including ARDS or death, did not occur in this large, multicentre cohort. Thoracoscopic talc poudrage using larger particle talc to prevent recurrence of PSPS can be considered safe.
- Published
- 2011
- Full Text
- View/download PDF
30. [Health promotion from the 20th to the 21th century. The Valais Ligue for fighting tuberculosis--a visionary model started in 1951].
- Author
-
Tschopp JM, Moix JB, and Dupuis G
- Subjects
- History, 20th Century, History, 21st Century, Hospitals, Chronic Disease history, Humans, Lung Diseases history, Public Health history, Risk Factors, Sculpture history, Smoking adverse effects, Smoking history, Societies, Medical history, Switzerland, Tuberculosis, Pulmonary prevention & control, Health Promotion history, Health Promotion trends, Lung Diseases prevention & control, Patient Education as Topic history, Tuberculosis, Pulmonary history
- Abstract
At the beginning of the twentieth century, tuberculosis was really a plague. Many people had been mobilised to successfully fight against this infectious disease. Valais, a Swiss alpine canton developped then an original concept of health promotion by involving all the health partners including a specialised hospital under the auspices of the local Health Departement. Such a model named then Ligue pulmonaire contre la tuberculose, celebrates his 60th anniversary. Its present name is Valais Health Promotion, i.e., a proactive health network very unique in Switzerland. It assumes many tasks of public health in clinical as well as in preventive medicine. These two components strongly facilitate the insertion of this organisation into the reality of this population to fulfil many challenging tasks with efficacy.
- Published
- 2011
31. Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery.
- Author
-
Licker M, Schnyder JM, Frey JG, Diaper J, Cartier V, Inan C, Robert J, Bridevaux PO, and Tschopp JM
- Subjects
- Acute Lung Injury mortality, Adenocarcinoma mortality, Adenocarcinoma surgery, Adenocarcinoma of Lung, Adult, Aged, Aging, Arrhythmias, Cardiac etiology, Arrhythmias, Cardiac mortality, Bronchopneumonia mortality, Cohort Studies, Female, Heart Failure etiology, Heart Failure mortality, Humans, Hypertension complications, Hypertension physiopathology, Incidence, Lung Neoplasms surgery, Male, Middle Aged, Myocardial Infarction etiology, Myocardial Infarction mortality, Oxygen Consumption physiology, Postoperative Complications etiology, Pulmonary Atelectasis etiology, Pulmonary Atelectasis mortality, Retrospective Studies, Risk Factors, Exercise physiology, Lung Neoplasms mortality, Physical Endurance physiology, Postoperative Complications physiopathology
- Abstract
Over the past decades, major progress in patient selection, surgical techniques and anaesthetic management have largely contributed to improved outcome in lung cancer surgery. The purpose of this study was to identify predictors of post-operative cardiopulmonary morbidity in patients with a forced expiratory volume in 1 s <80% predicted, who underwent cardiopulmonary exercise testing (CPET). In this observational study, 210 consecutive patients with lung cancer underwent CPET with completed data over a 9-yr period (2001-2009). Cardiopulmonary complications occurred in 46 (22%) patients, including four (1.9%) deaths. On logistic regression analysis, peak oxygen uptake (peak V'(O₂) and anaesthesia duration were independent risk factors of both cardiovascular and pulmonary complications; age and the extent of lung resection were additional predictors of cardiovascular complications, whereas tidal volume during one-lung ventilation was a predictor of pulmonary complications. Compared with patients with peak V'(O₂) >17 mL·kg⁻¹·min⁻¹, those with a peak V'(O₂) <10 mL·kg⁻¹·min⁻¹ had a four-fold higher incidence of cardiac and pulmonary morbidity. Our data support the use of pre-operative CPET and the application of an intra-operative protective ventilation strategy. Further studies should evaluate whether pre-operative physical training can improve post-operative outcome.
- Published
- 2011
- Full Text
- View/download PDF
32. [Foreign bodies and hemoptysis: about danger of ingesting blister-wrapped tablets].
- Author
-
Bosson V, Schnyder JM, and Tschopp JM
- Subjects
- Aged, Diagnosis, Differential, Hemoptysis diagnosis, Humans, Tablets, Drug Packaging, Foreign Bodies complications, Hemoptysis etiology
- Abstract
A case of hemoptysis may be challenging for clinicians because of the many etiologies involved in this differential diagnosis. Sometimes the cause of this symptom may be very surprising. We present a case of hemoptysis due to ingestion of a blister. This case illustrates the difficulties of identifying rare causes of hemoptysis, especially blister ingestion frequently occurring in old and neurological or cognitive impaired patients.
- Published
- 2011
33. [Cystic fibrosis, a paradigm for modern medicine].
- Author
-
Tschopp JM
- Subjects
- Child, Chronic Disease, Cystic Fibrosis epidemiology, Cystic Fibrosis physiopathology, Humans, Prognosis, Survival, Cystic Fibrosis therapy, Patient Care standards
- Abstract
Cystic fibrosis is the most frequent and severe genetic disorder in caucasian children. It is a multisystemic disease progressively involving many organs. Patients' survival was poor most of them dying as children. There has been now however an important improvement of prognosis. The median survival is 38 years today. Such a progress is related to comprehensive care based not only on scientific research but multidisciplinary clinical approach implying physicians and paramedics. Moreover pediatricians stimulated already in the 1960s patient autonomy by supporting national and international patients organisations. This approach has greatly contributed to increase the visibility of this disease and its support in our society. Cystic fibrosis is a paradigm for improving care of chronic diseases in medicine.
- Published
- 2011
34. [Medical thoracoscopy].
- Author
-
Schnyder JM and Tschopp JM
- Subjects
- Humans, Pleural Diseases etiology, Pleural Diseases pathology, Pleural Effusion etiology, Pleural Effusion pathology, Pleurodesis methods, Quality of Life, Recurrence, Talc administration & dosage, Pleural Diseases diagnosis, Pleural Effusion diagnosis, Pneumothorax therapy, Thoracoscopy methods
- Abstract
Medical thoracoscopy (MT) remains a mini-invasive and very efficient technique to diagnose pleural diseases. In case of pleural effusion of unknown etiology its diagnostic yield is higher than 90%. MT also allows to perform cheap and successful pleurodesis by simple talc insufflation in case of recurring pneumothorax and invalidating malignant pleural effusion with very poor quality of life despite repeated thoracocentes.
- Published
- 2011
35. [Talc pleurodesis by thoracoscopy: a minimally invasive technique finally legal].
- Author
-
Tschopp JM, Frey JG, Schnyder JM, and Astoul P
- Subjects
- Europe, Humans, Minimally Invasive Surgical Procedures methods, United States, United States Food and Drug Administration, Pleurodesis methods, Talc administration & dosage, Thoracoscopy methods
- Published
- 2011
36. Risk factors of acute kidney injury according to RIFLE criteria after lung cancer surgery.
- Author
-
Licker M, Cartier V, Robert J, Diaper J, Villiger Y, Tschopp JM, and Inan C
- Subjects
- Acute Kidney Injury classification, Acute Kidney Injury epidemiology, Aged, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Severity of Illness Index, Survival Rate trends, Switzerland epidemiology, Acute Kidney Injury etiology, Lung Neoplasms surgery, Pneumonectomy adverse effects
- Abstract
Background: Perioperative acute kidney injury (AKI) is associated with increased mortality and morbidity. Our aim was to evaluate the incidence and determinants of AKI using the risk, injury, failure, loss of function, and end-stage kidney disease (RIFLE) criteria in thoracic surgical patients., Methods: We retrospectively analyzed a cohort of patients undergoing lung cancer surgery from 1996 to 2009. Patient management was protocol-driven, and postoperative complications were prospectively collected. The primary outcome was AKI within 3 days after surgery. A variety of patient comorbidities and operative characteristics were evaluated as potential predictors of AKI using a multiple logistic regression model., Results: Complete data were obtained from 1,345 patients, and the incidence of AKI was 6.8%. Four independent risk factors for AKI were identified: American Society of Anesthesiologists classes 3 and 4 (odds ratio [OR] 2.60, 95% confidence interval [CI]: 1.03 to 6.55), forced expiratory volume in 1 second (OR 0.55, 95% CI: 0.32 to 0.96), the use of vasopressors (OR 1.015, 95% CI: 0.998 to 1.035), and the duration of anesthesia (OR 1.044, 95% CI: 1.001 to 1.008). Patients who experienced AKI were more frequently admitted to the intensive care unit (24.2% versus 3.5% for patients without AKI, p < 0.05); they had increased mortality (19.8% versus 1.1%, p < 0.05) and a threefold to fourfold higher incidence of cardiopulmonary complications., Conclusions: The RIFLE classification is a valuable tool to assess AKI after lung cancer surgery. The severity of perioperative renal impairment is associated with increased mortality and morbidity., (Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
37. [Cystic fibrosis and the practitioner: a paradigm for modern medicine].
- Author
-
Tschopp JM
- Subjects
- Cystic Fibrosis mortality, Humans, Patient Care Team, Cystic Fibrosis therapy, Disease Management
- Published
- 2011
38. Titrated sedation with propofol for medical thoracoscopy: a feasibility and safety study.
- Author
-
Tschopp JM, Purek L, Frey JG, Schnyder JM, Diaper J, Cartier V, and Licker M
- Subjects
- Adult, Aged, Aged, 80 and over, Feasibility Studies, Female, Humans, Lung Diseases diagnosis, Lung Diseases surgery, Male, Middle Aged, Pleural Diseases diagnosis, Pleural Diseases surgery, Retrospective Studies, Treatment Outcome, Conscious Sedation methods, Consciousness Monitors, Hypnotics and Sedatives administration & dosage, Hypnotics and Sedatives adverse effects, Propofol administration & dosage, Propofol adverse effects, Thoracoscopy methods
- Abstract
Background: Bispectral index (BIS) is a valuable tool for assessing the depth of sedation and guiding the administration of sedative drugs. We previously demonstrated the benefits of BIS-guided propofol sedation in patients undergoing flexible bronchoscopy., Objective: To examine the feasibility and safety profile of propofol sedation in patients undergoing medical thoracoscopy (MT)., Methods: Patients undergoing MT for diagnostic evaluation or treatment of pleuropulmonary diseases were enrolled over a 2-year period. Nurses and chest physicians were trained by anesthetists to provide analgosedation, to detect and correct cardiopulmonary disturbances. The level of sedation was optimized individually by titrating the propofol infusion according to the BIS and clinical evaluation. Patients' clinical data, procedure time, medications and any adverse events were recorded., Results: Fifty-three patients (60% male) with a median age of 62 years (range 19-84 years) underwent MT. The operative procedure lasted a median time of 28 min (range 9-112 min). The median doses of anesthetic drugs were 145 mg of propofol (range 20-410 mg) and 84 μg of fentanyl (range 0-225 μg). Hemodynamic disturbances occurred in 39 patients (bradycardia n = 4, tachycardia n = 12, hypotension n = 34) and required drug administration in only 4 cases. Hypoxemic events (n = 4) resolved upon gentle patient stimulation (verbal command, chin lift, oral cannula). All patients could be discharged from the recovery unit within 105 min after the procedure., Conclusions: BIS-guided propofol sedation is a safe method that might replace midazolam sedation in MT and can be managed by well-trained nonanesthesiologist personnel., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
39. Editorial. Thoracoscopy 1910-2010: serendipity.
- Author
-
Tschopp JM, Tassi GF, and Bolliger CT
- Subjects
- Humans, Thoracoscopy trends
- Published
- 2011
- Full Text
- View/download PDF
40. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.
- Author
-
Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, Braendli O, Brutsche M, Burdet L, Frey M, Gerbase MW, Ackermann-Liebrich U, Pons M, Tschopp JM, Rochat T, and Russi EW
- Subjects
- Adult, Age Factors, Aged, Airway Obstruction physiopathology, Asthma epidemiology, Asthma physiopathology, Cohort Studies, Female, Humans, Male, Middle Aged, Prevalence, Quality of Life, Respiratory Function Tests, Risk Factors, Severity of Illness Index, Sex Factors, Smoking physiopathology, Switzerland epidemiology, Airway Obstruction epidemiology, Smoking epidemiology
- Abstract
The aim of the present study was to measure age-specific prevalence of airflow obstruction in Switzerland in smokers and never-smokers using pulmonary function tests and respiratory symptoms from 6,126 subjects participating in the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults. The lower limit of normal of the forced expiratory volume in 1 s/forced vital capacity ratio was used to define airflow obstruction. Severity of airflow obstruction was graded according to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease. Prevalence of airflow obstruction ranged from 2.5% in subjects aged 30-39 yrs to 8.0% in those aged ≥ 70 yrs. In multivariate analysis, age (OR 2.8, ≥ 70 yrs versus 30-39 yrs), smoking (OR 1.8) and asthma (OR 6.7) were associated with airflow obstruction. Never-smokers constituted 29.3% of subjects with airflow obstruction. Never-smokers with airflow obstruction were younger, more likely to be male and reported asthma more frequently than obstructive smokers. Obstructive smokers and never-smokers had similar level of symptoms and quality of life impairment. The prevalence of airflow obstruction in Switzerland is similar to other developed countries. Never-smokers account for a third of the prevalence, which is higher proportion than elsewhere. Airflow obstruction in never-smokers deserves attention because of its frequency and its similar health impact to that in smokers.
- Published
- 2010
- Full Text
- View/download PDF
41. The centenary of medical thoracoscopy.
- Author
-
Tassi GF and Tschopp JM
- Subjects
- History, 20th Century, History, 21st Century, Humans, Multicenter Studies as Topic history, Thoracic Surgery, Video-Assisted trends, Thoracic Surgery, Video-Assisted history
- Published
- 2010
- Full Text
- View/download PDF
42. Comparison of cardiac output as assessed by transesophageal echo-Doppler and transpulmonary thermodilution in patients undergoing thoracic surgery.
- Author
-
Diaper J, Ellenberger C, Villiger Y, Robert J, Inan C, Tschopp JM, and Licker M
- Subjects
- Aged, Blood Pressure physiology, Heart Rate physiology, Humans, Lung Neoplasms surgery, Middle Aged, Prospective Studies, Respiration, Artificial methods, Thermodilution, Treatment Outcome, Cardiac Output physiology, Echocardiography, Doppler, Pulsed, Echocardiography, Transesophageal, Pneumonectomy
- Abstract
Study Objective: To evaluate the accuracy of cardiac index (CI) as measured by echo-transesophageal Doppler monitoring (echo-TDM) with CI measured by the transpulmonary thermodilution technique., Design: Prospective, observational study., Setting: University hospital., Patients: 16 patients scheduled for elective lung cancer resection., Interventions: Patients underwent two-lung ventilation (TLV) and one-lung ventilation (OLV)., Measurements and Main Results: CI measurements were analyzed using Bland-Altman plots. Absolute values of CI as measured by both devices were highly correlated (r(2) ranging from 0.72 to 0.77), as were relative changes in CI after the start of OLV (r(2) = 0.48, P = 0.006). Before, during, and after OLV, TDM-CI biases were 0.46 +/- 0.28 L/min/m(2), 0.25 +/- 0.18 L/min/m(2), and 0.35 +/- 0.29 L/min/m(2), respectively. Limits of agreement remained stable throughout the three measurement periods (range -1.08 to 0.21 L/min/m(2)). The mean percentage error of CI measurements was 21.9% compared with the thermodilution technique. Although no adverse events were reported, 11% of measurement sets were incomplete due to poor signal detection., Conclusions: Echo-TDM is a safe technique, allowing continuous semi-invasive assessment of hemodynamic changes in most patients undergoing open-chest surgery. Doppler-derived CI values showed significant biases and moderate clinical agreement with transpulmonary thermodilution during TLV and OLV., (Copyright 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
43. Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort.
- Author
-
Probst-Hensch NM, Curjuric I, Pierre-Olivier B, Ackermann-Liebrich U, Bettschart RW, Brändli O, Brutsche M, Burdet L, Gerbase MW, Knöpfli B, Künzli N, Pons MG, Schindler C, Tschopp JM, Rochat T, and Russi EW
- Subjects
- Adolescent, Adult, Dyspnea etiology, Early Diagnosis, Epidemiologic Methods, Female, Forced Expiratory Volume, Health Services statistics & numerical data, Humans, Male, Middle Aged, Prognosis, Pulmonary Disease, Chronic Obstructive complications, Pulmonary Disease, Chronic Obstructive epidemiology, Pulmonary Disease, Chronic Obstructive physiopathology, Spirometry methods, Switzerland epidemiology, Vital Capacity, Young Adult, Pulmonary Disease, Chronic Obstructive diagnosis
- Abstract
Background: Understanding the prognostic meaning of early stages of chronic obstructive pulmonary disease (COPD) in the general population is relevant for discussions about underdiagnosis. To date, COPD prevalence and incidence have often been estimated using prebrochodilation spirometry instead of postbronchodilation spirometry. In the SAPALDIA (Swiss Study on Air Pollution and Lung Disease in Adults) cohort, time course, clinical relevance and determinants of severity stages of obstruction were investigated using prebronchodilator spirometry., Methods: Incident obstruction was defined as an FEV(1)/FVC (forced expiratory volume in 1 s/forced vital capacity) ratio >or=0.70 at baseline and <0.70 at follow-up, and non-persistence was defined inversely. Determinants were assessed in 5490 adults with spirometry and respiratory symptom data in 1991 and 2002 using Poisson regression controlling for self-declared asthma and wheezing. Change in obstruction severity (defined analogously to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) classification) over 11 years was related to shortness of breath and health service utilisation for respiratory problems by logistic models., Results: The incidence rate of obstruction was 14.2 cases/1000 person years. 20.9% of obstructive cases (n = 113/540) were non-persistent. Age, smoking, chronic bronchitis and non-current asthma were determinants of incidence. After adjustment for asthma, only progressive stage I or persistent stage II obstruction was associated with shortness of breath (OR 1.71, 95% CI 0.83 to 3.54; OR 3.11, 95% CI 1.50 to 6.42, respectively) and health service utilisation for respiratory problems (OR 2.49, 95% CI 1.02 to 6.10; OR 4.17 95% CI 1.91 to 9.13, respectively) at follow-up., Conclusions: The observed non-persistence of obstruction suggests that prebronchodilation spirometry, as used in epidemiological studies, might misclassify COPD. Future epidemiological studies should consider both prebronchodilation and postbronchodilation measurements and take specific clinical factors related to asthma and COPD into consideration for estimation of disease burden and prediction of health outcomes.
- Published
- 2010
- Full Text
- View/download PDF
44. Titrated sedation with propofol or midazolam for flexible bronchoscopy: a randomised trial.
- Author
-
Clark G, Licker M, Younossian AB, Soccal PM, Frey JG, Rochat T, Diaper J, Bridevaux PO, and Tschopp JM
- Subjects
- Adult, Aged, Anesthetics, Intravenous administration & dosage, Drug Administration Schedule, Electroencephalography methods, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Prospective Studies, Treatment Outcome, Bronchoscopy methods, Midazolam administration & dosage, Propofol administration & dosage
- Abstract
In this study, we questioned whether propofol provided clinical benefits compared with midazolam in terms of neuropsychometric recovery, safety profile and patient tolerance. Patients, aged >18 yrs, were randomised to receive midazolam or propofol, given by non-anaesthetist physicians to achieve moderate levels of sedation as assessed by the electroencephalographic bispectral index (BIS; between 70 and 85). The primary end-point was the time delay until recovery of the BIS above 90. Other end-points included a neuropsychometric continuous performance test (CPT), serious respiratory adverse events, patient tolerance and physician satisfaction. Neuropsychometric recovery was improved in the propofol compared to the midazolam group as evidenced by faster normalisation of BIS index (5.4+/-4.7 min versus 11.7+/-10.2 min; p = 0.001) and better results at the CPT. In the midazolam group, 15% of patients presented profound sedation precluding CPT completion and one patient required mechanical ventilatory support. Patient tolerance was significantly better in the propofol group, whereas the operator's assessment was comparable in both groups. Compared with midazolam, propofol provided a higher quality of sedation in terms of neuropsychometric recovery and patient tolerance. BIS-guided propofol administration represents a safe sedation technique that can be performed by the non-anaesthesiologist.
- Published
- 2009
- Full Text
- View/download PDF
45. [Internal medicine, interdisciplinary medicine].
- Author
-
Tschopp JM and Petignat PA
- Subjects
- Female, Humans, Male, Switzerland, Internal Medicine, Patient Care Team
- Published
- 2009
46. [Retroperitoneal fibrosis: a rare cause of postrenal kidney failure, no to be missed].
- Author
-
Hemett OM, Tschopp JM, Meier P, Uldry PY, and Abbet P
- Subjects
- Administration, Oral, Adult, Aged, Anti-Inflammatory Agents administration & dosage, Anti-Inflammatory Agents therapeutic use, Biopsy, Follow-Up Studies, Glucocorticoids administration & dosage, Glucocorticoids therapeutic use, Humans, Immunosuppressive Agents therapeutic use, Injections, Intravenous, Male, Methylprednisolone administration & dosage, Methylprednisolone therapeutic use, Middle Aged, Prednisone administration & dosage, Prednisone therapeutic use, Radiography, Abdominal, Renal Dialysis, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Hydronephrosis complications, Renal Insufficiency etiology, Retroperitoneal Fibrosis complications, Retroperitoneal Fibrosis diagnosis, Retroperitoneal Fibrosis drug therapy, Retroperitoneal Fibrosis etiology, Retroperitoneal Fibrosis immunology, Retroperitoneal Fibrosis pathology
- Abstract
We report the observation of a fifty years old man, admitted in the emergency room for bilateral lumbar pain and hyperkaliemic metabolic acidosis, and postrenal kidney failure induced by bilateral hydronephrosis. Radiographic exploration and histologic studies of biopsy confirmed an idiopathic retroperitoneal fibrosis that clinically and biologicaly responded to three seances of hemodialysis, and insertion in each uretere of one double J stent, and long term corticotherapy. The retroperitoneal fibrosis is a little common inflammatory disease, characterized by the development of a fibrous mass around the retroperitoneal structures. His diagnostic means evolved. On the other hand, his treatment was the object of no checked controlled and randomized trial. This article proposes an updating of the knowledge on this subject.
- Published
- 2009
47. [Referring to an unusual case: pulmonary affection and rheumatoid arthritis].
- Author
-
Borges H, Schnyder JM, Frey JG, and Tschopp JM
- Subjects
- Anti-Bacterial Agents therapeutic use, Antirheumatic Agents administration & dosage, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid physiopathology, Bronchiectasis etiology, Dyspnea etiology, Female, Humans, Immunosuppressive Agents administration & dosage, Immunosuppressive Agents therapeutic use, Isoxazoles administration & dosage, Isoxazoles therapeutic use, Leflunomide, Lung Diseases drug therapy, Lung Diseases therapy, Middle Aged, Pleural Diseases etiology, Pneumothorax blood, Pneumothorax diagnostic imaging, Pneumothorax therapy, Pulmonary Emphysema etiology, Radiography, Thoracic, Recurrence, Tetracycline therapeutic use, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha antagonists & inhibitors, Anti-Bacterial Agents administration & dosage, Arthritis, Rheumatoid complications, Lung Diseases etiology, Pleurodesis methods, Pneumothorax etiology, Tetracycline administration & dosage
- Abstract
We report the case of a 60 year female patient suffering from rheumatoid arthritis for the last 25 years, under TNF-blocker and leflunomide, affected by a recurrent pneumothorax with several subpleural nodules, basal bronchiectasis and apical bullous emphysema. The patient was administered several treatments: aspiration, talc pleurodesis, surgical pleurodesis, pleurodesis induced by tetracycline and autologous blood. To allow the pleural inflammatory reaction necessary to the success of the pleurodesis, we had to interrupt the treatment by TNF-blocker and leflunomide. We then witnessed a partial pleurodesis with persistence of a pneumothorax. The medical situation is improving with disappearance of dyspnea.
- Published
- 2009
48. [Bronchopleural fistula: a serious complication after thoracic surgery].
- Author
-
Purek L, Licker M, Frey JG, Spiliopoulos A, and Tschopp JM
- Subjects
- Bronchial Fistula diagnosis, Bronchial Fistula surgery, Humans, Pleural Diseases diagnosis, Pleural Diseases surgery, Risk Factors, Bronchial Fistula etiology, Pleural Diseases etiology, Pneumonectomy adverse effects
- Abstract
Postsurgical bronchopleural fistula (BPF) is a serious complication accompanied with a high mortality, requiring early and correct diagnosis. The acute form of BPF is usually a technical failure of the surgical stump requiring an immediate surgical reoperation. The subacute or chronic BPF is more difficult to diagnose because of non specific symptoms. It requires well targeted antibiotics depending on microbiology, an adequate drainage of the thoracic cavity and very often repeated surgical or endoscopic procedures.
- Published
- 2009
49. [If physicians would look past the end of their nose...].
- Author
-
Tschopp JM and Frey JG
- Subjects
- Humans, Public Health, Physician's Role, Politics
- Published
- 2009
50. [Bochdalek hernia: a rare cause of dyspnea and abdominal pain in adults].
- Author
-
Jandus P, Savioz D, Purek L, Frey JG, Schnyder JM, and Tschopp JM
- Subjects
- Hernia, Diaphragmatic diagnosis, Hernia, Diaphragmatic surgery, Humans, Male, Middle Aged, Abdominal Pain etiology, Dyspnea etiology, Hernia, Diaphragmatic complications
- Abstract
We present here a case of a sixty year old man with a symptomatic hernia of Bochdalek. Its diagnostic was long to be established because this type of congenital diaphragmatic hernia is rare and mainly occurs in neonates. However when looking at a patient with dyspnea and lasting atypical abdominal pain, such a diagnosis has to be looked for, even if such a clinical entity is extremely rare in adults.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.